Envestnet Asset Management Inc. Has $211.60 Million Stake in MetLife, Inc. $MET

Envestnet Asset Management Inc. reduced its holdings in MetLife, Inc. (NYSE:MET) by 14.9% during the 3rd quarter, Holdings Channel reports. The fund owned 2,568,936 shares of the financial services provider’s stock after selling 448,986 shares during the quarter. Envestnet Asset Management Inc.’s holdings in MetLife were worth $211,603,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of MetLife during the second quarter worth $756,104,000. ABN AMRO Bank N.V. acquired a new stake in MetLife in the 2nd quarter valued at about $178,669,000. Amundi raised its stake in shares of MetLife by 40.2% in the second quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock worth $361,265,000 after acquiring an additional 1,292,107 shares during the last quarter. Man Group plc lifted its position in shares of MetLife by 325.5% during the second quarter. Man Group plc now owns 1,344,551 shares of the financial services provider’s stock worth $108,129,000 after purchasing an additional 1,028,554 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC grew its stake in shares of MetLife by 1,028.2% during the second quarter. Worldquant Millennium Advisors LLC now owns 856,905 shares of the financial services provider’s stock valued at $68,912,000 after purchasing an additional 780,955 shares during the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Management unveiled a strategic “New Frontier” plan targeting double‑digit adjusted EPS growth and a $25 billion free‑cash‑flow target over the coming years — a clear investor-friendly, capital-allocation signal that supports higher long‑term value. Read More.
• Positive Sentiment: Company reported strong operational momentum in Group Benefits, RIS and Asia that lifted adjusted EPS and drove year‑over‑year PFO growth; several outlets flagged an adjusted‑EPS beat for the quarter, which underpins the bullish forward outlook. Read More.
• Neutral Sentiment: Wall Street reactions were generally constructive — analyst roundups show multiple Buy/Overweight ratings and above‑consensus price targets (median ~$97), suggesting analysts are valuing the strategic targets more than short‑term noise. Read More.
• Neutral Sentiment: Management provided the full earnings‑call transcript and a CFO update video for investors seeking detail — useful for digging into the adjusted vs GAAP metrics and segment drivers. Read More.
• Negative Sentiment: GAAP and some headline numbers looked weaker: certain reporters flagged revenue misses and lower GAAP net income/diluted EPS versus prior year or consensus, which creates short‑term selling pressure as investors reconcile adjusted results with GAAP metrics. Read More.
• Negative Sentiment: Near‑term headwinds called out on the call include a Mexico VAT impact and credit pressures in some portfolios; research pieces asked whether Asia growth can fully offset credit and other short‑term drags. Those items likely explain part of the intraday weakness. Read More.

MetLife Price Performance

Shares of MET opened at $75.36 on Friday. The stock has a market cap of $49.66 billion, a P/E ratio of 16.03, a price-to-earnings-growth ratio of 0.74 and a beta of 0.77. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $87.39. The stock’s 50-day moving average price is $78.90 and its two-hundred day moving average price is $78.81. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $0.24. MetLife had a net margin of 4.38% and a return on equity of 21.89%. The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $31.43 billion. During the same period last year, the company posted $2.08 EPS. MetLife’s revenue for the quarter was up 27.6% on a year-over-year basis. On average, equities analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be issued a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 3.0%. MetLife’s payout ratio is 48.30%.

Analysts Set New Price Targets

Several research analysts recently weighed in on MET shares. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Mizuho set a $102.00 target price on MetLife in a research report on Wednesday, January 14th. Wells Fargo & Company raised their price target on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a report on Tuesday, January 13th. Barclays set a $90.00 price objective on MetLife in a report on Thursday, January 8th. Finally, Evercore ISI set a $97.00 target price on shares of MetLife and gave the company an “in-line” rating in a research note on Tuesday, January 6th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $95.64.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.